Blue Cross Blue Shield of Massachusetts denied her asthma coverage. Then she died.

A License to Kill: How Federal Law Protects Insurers Who Deny a Dying Man an Inhaler

The Non-Financial Ledger

This is a story about a piece of paper. A denial letter, sent by the “Pharmacy Operations Unit” of a multi-billion dollar corporation, Blue Cross Blue Shield of Massachusetts. That letter, dated March 25, 2020, contained the fate of Blaise Cannon.

Blaise had asthma. His doctor, a medical expert who had examined him, prescribed a specific medication: a Wixela Inhub inhaler. This was a medical decision made between a patient and his physician. BCBS intervened. The corporation, which never examined Blaise, decided the doctor was wrong, or at least, premature. Their denial was not a medical counter-opinion. It was an administrative ruling based on a profit-driven checklist.

The letter stated that there was no proof Blaise had already tried a “prescription inhaled steroid, inhaled beta-agonist, inhaled mast cell stabilizer, oral albuterol, or theophylline product within the previous 130 days.” It was a bureaucratic wall. A demand for Blaise to suffer through less effective or inappropriate treatments before the company would approve the one his doctor ordered. Blaise Cannon did not appeal. He later died from complications of his asthma.

The loss recorded here is not about the cost of an inhaler. It is about the loss of dignity in seeking care. It is about the betrayal of a system that promises security and delivers deadly red tape. The ledger shows one human life, extinguished, against a backdrop of corporate policy designed to minimize costs, regardless of the human price.

Legal Receipts: The System Justifies Itself

When Blaise Cannon’s family sought justice through a wrongful death lawsuit, they ran into a legal fortress called ERISA. The courts were not asked to decide if BCBS’s denial was immoral or if it caused his death. They were only asked if federal law gave the family the right to sue for damages in the first place. The answer was no. The court’s own words expose the architecture of this corporate shield.

The Denial Justification

This is the language BCBS used to deny a dying man medicine, straight from the court record. It is a masterclass in bureaucratic indifference:

The Iron Wall of Preemption

The court explains why a state law meant to provide justice for a wrongful death is irrelevant. The federal ERISA law simply erases it.

The message is clear: any attempt to hold the plan accountable for its actions is considered “relating to” the plan, and is therefore forbidden.

The Empty Remedy

The court confirms that under ERISA, you can sue to get your benefits, but you cannot sue for the harm caused when those benefits are denied. For Blaise Cannon, this meant he could have sued to get the inhaler, but his family cannot sue for his death after the denial.

Societal Impact Mapping

Public Health Catastrophe

ERISA creates a perverse incentive for insurance companies. Denying care is profitable. If the patient gets sicker or dies, the law protects the insurer from financial liability for the consequences. This fundamentally corrupts healthcare. Medical professionals are overruled by corporate employees following flowcharts designed to maximize profit. The result is a system where easily preventable tragedies like Blaise Cannon’s death become a calculated cost of doing business, a cost borne entirely by patients and their families.

Economic Inequality

Because ERISA governs employer-sponsored health plans, it deepens the divide between the secure and the precarious. Your ability to fight a wrongful denial, or even survive it, is tied to your employment. A wrongful death claim might be the only financial recourse for a family that has lost a primary earner. By preempting these claims, ERISA ensures that the economic devastation caused by a corporate decision remains with the victim’s family, further entrenching generational poverty and instability.

The Price of an Inhaler
The Value of a Human Life Under ERISA

The core of this case is a sickening calculation. Blue Cross Blue Shield of Massachusetts saved the cost of one Wixela Inhub inhaler. In return for this minor financial saving, a man died. The legal system, bound by ERISA, has ruled that the value of the life lost in this transaction is legally zero. The family is entitled to no damages for the death of their loved one. The law provides no mechanism to make the company pay for the ultimate consequence of its denial. This is the math of American healthcare.

What Now? The Resistance

The courts have affirmed that they are a dead end. The First Circuit Court of Appeals sided with Blue Cross Blue Shield. Justice for the victims of ERISA preemption will not be found in a courtroom; it must be demanded in the political arena.

Corporate Roles to Watch

Accountability is impossible without identifying the decision-makers. While names are redacted, the corporate structure is not.

  • Chief Medical Officer, BCBS of Massachusetts
  • Head of Pharmacy Operations, BCBS of Massachusetts
  • The Board of Directors, BCBS of Massachusetts

Regulatory Watchlist & Action

ERISA is a federal law. Only a federal response can fix it.

  • U.S. Congress: The only body that can amend or repeal ERISA’s preemption clause. Demand that your representatives sponsor and support legislation to restore the right of citizens to sue insurance companies for wrongful injury and death.
  • Department of Labor: The agency tasked with enforcing ERISA. It is consistently underfunded and overpowered by corporate legal teams. Support efforts to strengthen its enforcement capabilities.
  • Grassroots Organizing: Support mutual aid networks in your community that help people pay for medicine and navigate insurance bureaucracy. Join national movements fighting for Medicare for All or other systemic reforms that would make ERISA’s power over our health obsolete.

The source document for this investigation is attached below.

💡 Explore Corporate Misconduct by Category

Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.

Aleeia
Aleeia

I'm Aleeia, the creator of this website.

I have 6+ years of experience as an independent researcher covering corporate misconduct, sourced from legal documents, regulatory filings, and professional legal databases.

My background includes a Supply Chain Management degree from Michigan State University's Eli Broad College of Business, and years working inside the industries I now cover.

Every post on this site was either written or personally reviewed and edited by me before publication.

Learn more about my research standards and editorial process by visiting my About page

Articles: 1742
🏳️‍⚧️ trans rights are human rights 🏳️‍⚧️
Theme